FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2154938802> ?p ?o ?g. }

• W2154938802 endingPage "467" @default.
• W2154938802 startingPage "461" @default.
• W2154938802 abstract "Background The best way to manage restenosis in patients who have previously received a drug-eluting stent is unknown. We investigated the efficacy of paclitaxel-eluting balloons (PEB), paclitaxel-eluting stents (PES), and balloon angioplasty in these patients. Methods In this randomised, open-label trial, we enrolled patients older than 18 years with restenosis of at least 50% after implantation of any limus-eluting stent at three centres in Germany between Aug 3, 2009, and Oct 27, 2011. Patients were randomly assigned (1:1:1; stratified according to centre) to receive PEB, PES, or balloon angioplasty alone by means of sealed, opaque envelopes containing a computer-generated sequence. Patients and investigators were not masked to treatment allocation, but events and angiograms were assessed by individuals who were masked. The primary endpoint was diameter stenosis at follow-up angiography at 6–8 months. Primary analysis was done by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00987324. Findings We enrolled 402 patients, of whom 137 (34%) were assigned to PEB, 131 (33%) to PES, and 134 (33%) to balloon angioplasty. Follow-up angiography at 6-8 months was available for 338 (84%) patients. PEB was non-inferior to PES in terms of diameter stenosis (38·0% [SD 21·5] vs 37·4% [21·8]; difference 0·6%, one-sided 95% CI 4·9%; pnon-inferiority=0·007; non-inferiority margin of 7%). Findings were consistent in per-protocol analysis (pnon-inferiority=0·011). PEB and PES were superior to balloon angioplasty alone (54·1% [25·0]; psuperiority<0·0001 for both comparisons). Frequency of death, myocardial infarction, or target lesion thrombosis did not differ between groups. Interpretation By obviating the need for additional stent implantation, PEB could be a useful treatment for patients with restenosis after implantation of a drug-eluting stent. Funding Deutsches Herzzentrum. The best way to manage restenosis in patients who have previously received a drug-eluting stent is unknown. We investigated the efficacy of paclitaxel-eluting balloons (PEB), paclitaxel-eluting stents (PES), and balloon angioplasty in these patients. In this randomised, open-label trial, we enrolled patients older than 18 years with restenosis of at least 50% after implantation of any limus-eluting stent at three centres in Germany between Aug 3, 2009, and Oct 27, 2011. Patients were randomly assigned (1:1:1; stratified according to centre) to receive PEB, PES, or balloon angioplasty alone by means of sealed, opaque envelopes containing a computer-generated sequence. Patients and investigators were not masked to treatment allocation, but events and angiograms were assessed by individuals who were masked. The primary endpoint was diameter stenosis at follow-up angiography at 6–8 months. Primary analysis was done by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00987324. We enrolled 402 patients, of whom 137 (34%) were assigned to PEB, 131 (33%) to PES, and 134 (33%) to balloon angioplasty. Follow-up angiography at 6-8 months was available for 338 (84%) patients. PEB was non-inferior to PES in terms of diameter stenosis (38·0% [SD 21·5] vs 37·4% [21·8]; difference 0·6%, one-sided 95% CI 4·9%; pnon-inferiority=0·007; non-inferiority margin of 7%). Findings were consistent in per-protocol analysis (pnon-inferiority=0·011). PEB and PES were superior to balloon angioplasty alone (54·1% [25·0]; psuperiority<0·0001 for both comparisons). Frequency of death, myocardial infarction, or target lesion thrombosis did not differ between groups. By obviating the need for additional stent implantation, PEB could be a useful treatment for patients with restenosis after implantation of a drug-eluting stent." @default.
• W2154938802 created "2016-06-24" @default.
• W2154938802 creator A5007093669 @default.
• W2154938802 creator A5007787316 @default.
• W2154938802 creator A5012755919 @default.
• W2154938802 creator A5015669756 @default.
• W2154938802 creator A5016222066 @default.
• W2154938802 creator A5028965875 @default.
• W2154938802 creator A5048924859 @default.
• W2154938802 creator A5063282339 @default.
• W2154938802 creator A5064309744 @default.
• W2154938802 creator A5066812477 @default.
• W2154938802 creator A5066855244 @default.
• W2154938802 creator A5069679013 @default.
• W2154938802 creator A5070212671 @default.
• W2154938802 creator A5086795617 @default.
• W2154938802 creator A5089531887 @default.
• W2154938802 creator A5091776005 @default.
• W2154938802 date "2013-02-01" @default.
• W2154938802 modified "2023-10-18" @default.
• W2154938802 title "Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial" @default.
• W2154938802 cites W104885242 @default.
• W2154938802 cites W1428162896 @default.
• W2154938802 cites W146601392 @default.
• W2154938802 cites W1471736494 @default.
• W2154938802 cites W151737902 @default.
• W2154938802 cites W1522445824 @default.
• W2154938802 cites W1976566530 @default.
• W2154938802 cites W1986902729 @default.
• W2154938802 cites W1998917704 @default.
• W2154938802 cites W2005656672 @default.
• W2154938802 cites W2012105182 @default.
• W2154938802 cites W2019438168 @default.
• W2154938802 cites W2026168678 @default.
• W2154938802 cites W2028425022 @default.
• W2154938802 cites W2034221000 @default.
• W2154938802 cites W2055797210 @default.
• W2154938802 cites W2087150869 @default.
• W2154938802 cites W2087451376 @default.
• W2154938802 cites W2109769695 @default.
• W2154938802 cites W2111592624 @default.
• W2154938802 cites W2117036682 @default.
• W2154938802 cites W2129900778 @default.
• W2154938802 cites W2144860230 @default.
• W2154938802 cites W2157018249 @default.
• W2154938802 cites W2168077590 @default.
• W2154938802 cites W2169272176 @default.
• W2154938802 cites W2169468271 @default.
• W2154938802 cites W2186657631 @default.
• W2154938802 cites W2216295427 @default.
• W2154938802 cites W2216533123 @default.
• W2154938802 cites W3149209040 @default.
• W2154938802 doi "https://doi.org/10.1016/s0140-6736(12)61964-3" @default.
• W2154938802 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23206837" @default.
• W2154938802 hasPublicationYear "2013" @default.
• W2154938802 type Work @default.
• W2154938802 sameAs 2154938802 @default.
• W2154938802 citedByCount "327" @default.
• W2154938802 countsByYear W21549388022012 @default.
• W2154938802 countsByYear W21549388022013 @default.
• W2154938802 countsByYear W21549388022014 @default.
• W2154938802 countsByYear W21549388022015 @default.
• W2154938802 countsByYear W21549388022016 @default.
• W2154938802 countsByYear W21549388022017 @default.
• W2154938802 countsByYear W21549388022018 @default.
• W2154938802 countsByYear W21549388022019 @default.
• W2154938802 countsByYear W21549388022020 @default.
• W2154938802 countsByYear W21549388022021 @default.
• W2154938802 countsByYear W21549388022022 @default.
• W2154938802 countsByYear W21549388022023 @default.
• W2154938802 crossrefType "journal-article" @default.
• W2154938802 hasAuthorship W2154938802A5007093669 @default.
• W2154938802 hasAuthorship W2154938802A5007787316 @default.
• W2154938802 hasAuthorship W2154938802A5012755919 @default.
• W2154938802 hasAuthorship W2154938802A5015669756 @default.
• W2154938802 hasAuthorship W2154938802A5016222066 @default.
• W2154938802 hasAuthorship W2154938802A5028965875 @default.
• W2154938802 hasAuthorship W2154938802A5048924859 @default.
• W2154938802 hasAuthorship W2154938802A5063282339 @default.
• W2154938802 hasAuthorship W2154938802A5064309744 @default.
• W2154938802 hasAuthorship W2154938802A5066812477 @default.
• W2154938802 hasAuthorship W2154938802A5066855244 @default.
• W2154938802 hasAuthorship W2154938802A5069679013 @default.
• W2154938802 hasAuthorship W2154938802A5070212671 @default.
• W2154938802 hasAuthorship W2154938802A5086795617 @default.
• W2154938802 hasAuthorship W2154938802A5089531887 @default.
• W2154938802 hasAuthorship W2154938802A5091776005 @default.
• W2154938802 hasConcept C126838900 @default.
• W2154938802 hasConcept C139059822 @default.
• W2154938802 hasConcept C141071460 @default.
• W2154938802 hasConcept C168563851 @default.
• W2154938802 hasConcept C203092338 @default.
• W2154938802 hasConcept C2776694085 @default.
• W2154938802 hasConcept C2777292972 @default.
• W2154938802 hasConcept C2777546689 @default.
• W2154938802 hasConcept C2778283817 @default.
• W2154938802 hasConcept C2778583881 @default.
• W2154938802 hasConcept C2780007028 @default.

• next